title: Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles.
abstract: Introduction:Several authors have linked subclinical ovulatory disturbances in normal length menstrual cycles to premenopausal fracture risk and bone changes. This study systematically examined the influence of ovulation and anovulation on the bone metabolism of premenopausal women.Participants and Methods:In 176 cycles in healthy premenopausal women, FSH, 17β-estradiol (E2) and progesterone (P4) as well as bone alkalic phosphatase (BAP), pyridinoline (PYD) and C-terminal crosslinks (CTX) were measured during the follicular and during the luteal phase. The probability and timing of ovulation was self-assessed by a monitoring device. In addition, bone density of the lumbar spine was measured by quantitative computed tomography (QCT) at baseline and at the end of the study. Analysis was restricted to blood samples taken more than three days before the following menstruation.Results:118 cycles out of the 176 collected cycles were complete with blood samples taken within the correct time interval. Of these, 56.8 % were ovulatory by two criteria (ovulation symbol shown on the monitor display and LP progesterone > 6 ng/ml), 33.1 % were possibly ovulatory by one criterion (ovulation symbol shown on the monitor display or LP progesterone > 6 ng/ml), and 10.2 % were anovulatory by both criteria). Ovulation in the previous cycle and in the same cycle did not significantly influence the mean absolute concentrations of the bone markers. However, bone formation (BAP) was higher in the luteal phase of ovulatory cycles than in anovulatory cycles (n. s.) and the relative changes within one cycle were significantly different for bone resorption (CTX) during ovulatory vs. anovulatory cycles (p < 0.01). In 68 pairs of cycles following each other directly, both ovulation in the previous cycle and ovulation in the present cycle influenced CTX, but not the differences of other bone markers.Conclusion:Ovulatory cycles reduce bone resorption in their luteal phase and that of the following cycle. The interaction between ovulation and bone metabolism is complex. Since anovulation may occur in low estrogen states such as pre-anorexic dietary restraint, as well as with high estrogenic circumstances e.g. from functional perimenopausal ovarian cysts, the association with bone changes has been variable in the literature. Accumulating physiological and clinical evidence however point towards a role for ovulation in enhancing bone formation and limiting bone resorption.
authors.affiliation: Gyn. Endokrinologie, Frauenklinik und Poliklinik der TU München, München.
authors.forename: B
authors.initials: B
authors.lastname: Niethammer
authors.affiliation: Gyn. Endokrinologie, Frauenklinik und Poliklinik der TU München, München.
authors.forename: C
authors.initials: C
authors.lastname: Körner
authors.affiliation: Gyn. Endokrinologie, Frauenklinik und Poliklinik der TU München, München.
authors.forename: M
authors.initials: M
authors.lastname: Schmidmayr
authors.affiliation: Institut für klinische Chemie und Pathobiochemie der TU München, München.
authors.forename: P B
authors.initials: PB
authors.lastname: Luppa
authors.affiliation: Gyn. Endokrinologie, Frauenklinik und Poliklinik der TU München, München.
authors.forename: V R
authors.initials: VR
authors.lastname: Seifert-Klauss
keywords: anovulation; hormones; ovulation; premenopause